Collaborators
EpiVax is currently engaged in multiple collaborations focused on our Tregitope technology. For more information on any of the following collaborations please contact Jason Del Pozzo at bda@epivax.com.
| Collaborator |
Affiliation |
Target |
| |
|
|
| David Scott, Ph.D. |
University of Maryland |
Diabetes, FVIII |
| Achsah Keegan, Ph.D. |
University of Maryland |
Allergy |
| Mo Sayegh, M.D. |
Brigham and Women’s, Harvard University |
Transplantation |
| Nader Najafian, M.D. |
Brigham and Women’s, Harvard University |
Transplantation |
| Andrew Issekutz, M.D.. |
Dalhousie University |
IgG |
| Benoit Salomon |
CERV |
Uveitis |
| Ziad Mallat, M.D., Ph.D. |
INSERM |
Atherosclerosis |
| Katherine High, M.D. |
Children’s Hospital of Philadelphia |
Gene Therapy |
| Samia Khoury, M.D. |
Brigham and Women’s, Harvard University |
MS/EAE |
| Leslie De Groot, M.D. |
University of Rhode Island |
TSHR |
Previous Clients
| DeFT and/or PreDeFT |
Vaccine Design |
| Astrazeneca |
Acambis |
| Biosynexus |
Harvard University |
| BioMarin |
Dana Farber Cancer Institute |
| Eli Lilly |
Brown University |
| Maxygen |
University of Pennsylvania |
| MedImmune |
University of Massachusetts |
| Regeneron |
Miriam Hospital |
| Spinal Therapies |
MedImmune |
| Trophogen |
Rhode Island Hospital |
| |
University of Rhode Island |
| |
University of Rochester |
| |
Saint Louis University |
| |
Vanderbilt University |
| |
Tufts University |
